News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Manion Douglas J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| Manion Douglas J. (Pres and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,437 shares
@ $9.81, valued at
$43.5k
Exercised 15,575 restricted stock units
@ $0 |
|
| 03/17/2023 |
4
| Manion Douglas J. (Pres and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Bought 6,300 shares
@ $7.8623, valued at
$49.5k
|
|
| 03/09/2023 |
4
| Manion Douglas J. (Pres and CEO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Bought 6,500 shares
@ $7.735, valued at
$50.3k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2022 |
4
| Manion Douglas J. (Pres and COO) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 217,800 options to buy
@ $13.62, valued at
$3M
Granted 62,300 restricted stock units
@ $0 |
|
| 08/02/2022 |
3
| Manion Douglas J. (Pres and COO) has filed a Form 3 on Aclaris Therapeutics, Inc. |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Manion Douglas J. (EVP Research & Development) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 21,462 shares
@ $0 |
|
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|